Abstract
The chronic lymphocytic leukemia (CLL) diagnosis increases with age. We do not know CLL incidence in Mexico. Some risk factors for developing CLL are the inherited predisposition, monoclonal lymphocytosis, history of cancer and, probably, some infections. The diagnosis is established with a complete medical history, physical examination, and laboratory tests, among them, cytogenetic ones. The treatment choice will depend on age, performance status, comorbidities, cytogenetic alterations, clinical stage. In Oncoguía de leucemia linfocítica crónica, we include the criteria to begin treatment, and the drugs approved internationally and in our country. Likewise, we comprise the response criteria to the treatment and the recommendations for the support treatment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Latin american journal of clinical sciences and medical technology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
